FDA Approved: EPIDIOLEX — Supplemental Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Epidiolex (cannabidiol) from Jazz Pharmaceuticals, updating the labeling to reflect the new authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Lennox-gastaut Syndrome
• Tuberous Sclerosis Complex

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

SUPPL AP for EPIDIOLEX (CANNABIDIOL)